Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H11N3O3S |
| Molecular Weight | 301.32 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)NC1=NC2=CC(=CC=C2N1)C(=O)C3=CC=CS3
InChI
InChIKey=KYRVNWMVYQXFEU-UHFFFAOYSA-N
InChI=1S/C14H11N3O3S/c1-20-14(19)17-13-15-9-5-4-8(7-10(9)16-13)12(18)11-3-2-6-21-11/h2-7H,1H3,(H2,15,16,17,19)
Nocodazole is an anti-mitotic drug that has long been used as an experimental tool in cell biology. Nocodazole is known to bind with high affinity to tubulin and to inhibit microtubule assembly. The tubulin molecule is a α/β heterodimer; both α and β exist as various isotypes whose distribution and drug-binding properties are significantly different. Nocodazole has the highest affinity for αβIV and the lowest affinity for αβIII. In addition, nocodazole was investigated as an anticancer drug on xenografts model and it was revealed, that nocodazole possessed a high-affinity for the cancer-related kinases ABL, c-KIT, BRAF, and MEK, and inhibited Abl, Abl(E255K) and Abl(T315I).
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095182 |
|||
Target ID: P00519 Gene ID: 25.0 Gene Symbol: ABL1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/22002881 |
0.091 µM [Kd] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification and characterization of a family of Rab11-interacting proteins. | 2001-10-19 |
|
| Dual control of replication timing. Stochastic onset but programmed completion of mammalian chromosome duplication. | 2001-09-28 |
|
| Identification of novel bifunctional calmodulin-binding and microtubule-stabilizing motifs in STOP proteins. | 2001-08-17 |
|
| Movement of endoplasmic reticulum in the living axon is distinct from other membranous vesicles in its rate, form, and sensitivity to microtubule inhibitors. | 2001-08-01 |
|
| Mammalian Golgi-associated Bicaudal-D2 functions in the dynein-dynactin pathway by interacting with these complexes. | 2001-08-01 |
|
| Dioxin suppresses the checkpoint protein, MAD2, by an aryl hydrocarbon receptor-independent pathway. | 2001-08-01 |
|
| Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. | 2001-08 |
|
| Dissolution of poorly crystalline apatite crystals by osteoclasts determined on artificial thin-film apatite. | 2001-08 |
|
| Insulin stimulates membrane conductance in a liver cell line: evidence for insertion of ion channels through a phosphoinositide 3-kinase-dependent mechanism. | 2001-07-20 |
|
| The mouse Mps1p-like kinase regulates centrosome duplication. | 2001-07-13 |
|
| Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. | 2001-07-13 |
|
| Microtubules are involved in glucose-dependent dissociation of the yeast vacuolar [H+]-ATPase in vivo. | 2001-07-06 |
|
| Variation in adenovirus receptor expression and adenovirus vector-mediated transgene expression at defined stages of the cell cycle. | 2001-07 |
|
| Aneuploid colon cancer cells have a robust spindle checkpoint. | 2001-07 |
|
| Translocation of active mitochondria during pig oocyte maturation, fertilization and early embryo development in vitro. | 2001-07 |
|
| Effect of cytokinesis inhibitors, DMSO and the timing of oocyte activation on mouse cloning using cumulus cell nuclei. | 2001-07 |
|
| Cytochalasin D induces edema formation and lowering of interstitial fluid pressure in rat dermis. | 2001-07 |
|
| Brefeldin A block of integrin-dependent mechanosensitive ATP release from Xenopus oocytes reveals a novel mechanism of mechanotransduction. | 2001-06-29 |
|
| Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. | 2001-06-28 |
|
| Identification of a human orthologue of Sec34p as a component of the cis-Golgi vesicle tethering machinery. | 2001-06-22 |
|
| Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines. | 2001-06-01 |
|
| p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle. | 2001-06-01 |
|
| The Bub2-dependent mitotic pathway in yeast acts every cell cycle and regulates cytokinesis. | 2001-06 |
|
| The non-catalytic domain of the Xenopus laevis auroraA kinase localises the protein to the centrosome. | 2001-06 |
|
| Glucosylceramide synthesis inhibitors block pharmacologically induced dispersal of the Golgi and anterograde membrane flow from the endoplasmic reticulum: implication of sphingolipid metabolism in maintenance of the Golgi architecture and anterograde membrane flow. | 2001-06 |
|
| Endocytosis of NBD-sphingolipids in neurons: exclusion from degradative compartments and transport to the Golgi complex. | 2001-06 |
|
| Cytoplasmic changes in relation to nuclear maturation and early embryo developmental potential of porcine oocytes: effects of gonadotropins, cumulus cells, follicular size, and protein synthesis inhibition. | 2001-06 |
|
| Hypertonic activation of the renal betaine/GABA transporter is microtubule dependent. | 2001-06 |
|
| Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1. | 2001-06 |
|
| Cell-specific basolateral membrane sorting of the human liver Na(+)-dependent bile acid cotransporter. | 2001-06 |
|
| Mutations in the mitotic check point gene, MAD1L1, in human cancers. | 2001-05-31 |
|
| Regulation of microtubule assembly by human EB1 family proteins. | 2001-05-31 |
|
| Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. | 2001-05-24 |
|
| DCX in PC12 cells: CREB-mediated transcription and neurite outgrowth. | 2001-05-01 |
|
| Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. | 2001-05 |
|
| Apoptosis can be a confusing factor in in vitro clastogenic assays. | 2001-05 |
|
| Involvement of nuclear factor kappaB in c-Myc induction by tubulin polymerization inhibitors. | 2001-05 |
|
| Endothelial microtubule disruption blocks flow-dependent dilation of arterioles. | 2001-05 |
|
| Asymmetrical segregation of chromosomes with a normal metaphase/anaphase checkpoint in polyploid megakaryocytes. | 2001-04-15 |
|
| Association of bovine papillomavirus type 1 with microtubules. | 2001-04-10 |
|
| Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches. | 2001-04 |
|
| Determination of the net exchange rate of tubulin dimer in steady-state microtubules by fluorescence correlation spectroscopy. | 2001-03 |
|
| Functional integrity of the vesicle transporting machinery is required for complete activation of cFTR expressed in xenopus laevis oocytes. | 2001-03 |
|
| Growth arrest in A549 cells during hyperoxic stress is associated with decreased cyclin B1 and increased p21(Waf1/Cip1/Sdi1) levels. | 2001-02-05 |
|
| Nocodazole treatment of CV-1 cells enhances nuclear/perinuclear accumulation of lipid-DNA complexes and increases gene expression. | 2001-02 |
|
| Uptake of endocytic markers by rice cells: variations related to the growth phase. | 2001-02 |
|
| Mechanism of hyperploid cell formation induced by microtubule inhibiting drug in glioma cell lines. | 2001-01-25 |
|
| The effect of cytochalasin J on kinetochore structure in PtK1 cells is mitotic cycle dependent. | 2001 |
|
| Development of porcine embryos reconstituted with somatic cells and enucleated metaphase I and II oocytes matured in a protein-free medium. | 2001 |
|
| Microtubule-targeting drugs induce Bcl-2 phosphorylation and association with Pin1. | 2000-11-06 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12203371
tumor xenografts mice: 5 mg/kg/three times per week
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24360964
Nocodazole potently induced LATS2 expression in HEK293T cells. Consistently, nocodazole significantly inhibited β-catenin-mediated transcription induced by LiCl or β-Cat overexpression. There also were found that nocodazole induced LATS2, but not LATS1, in a time-dependent manner in HCT116 cells and SW480 cells. While nocodazole significantly suppressed the expression of AXIN2 and MMP7 in HCT116 cells expressing scramble shRNA (HCT116/Scrsh), it could not affect the expression of AXIN2 and MMP7 in HCT116 cells expressing LATS2 shRNA (HCT116/LATS2sh). The restoration of LATS2 or LATS2N in HCT116/LATS2sh cells suppressed the expression of AXIN2 and MMP7, confirming the specificity of LATS2 shRNA. Moreover, ChIP assays found that nocodazole induced LATS2 binding to the promoter of AXIN2 or MMP7 in HCT116/Scrsh cells, but not in HCT116/LATS2sh cells. Consistently, was found that the occupancy of BCL9 on the promoter of AXIN2 or MMP7 was reduced in HCT116/Scrch cells, but not in HCT116/LATS2sh cells, upon nocodazole treatment. In contrast, nocodazole did not interfere with β-catenin presence on the promoter of AXIN2 or MMP7. The constitutive activation of Wnt/β-catenin plays a critical role in human colorectal tumor growth.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
||
|
NCI_THESAURUS |
C25974
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB08313
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
3974
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
250-626-5
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
SUB09339MIG
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
34892
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
NOCODAZOLE
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
238159
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
31430-18-9
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
4122
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
C75228
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
SH1WY3R615
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL9514
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
100000083564
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY | |||
|
DTXSID9031800
Created by
admin on Wed Apr 02 07:43:27 GMT 2025 , Edited by admin on Wed Apr 02 07:43:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY